FDA approves third over-the-counter nasal spray to treat opioid drug overdoses

The FDA has approved a third over-the-counter nasal spray to combat opioid overdoses, highlighting the ongoing struggle with drug overdoses in the U.S. driven largely by synthetic opioids like fentanyl. With overdose deaths still high despite earlier successes with Narcan, this new approval aims to make life-saving naloxone more accessible. This move could help reduce the number of overdose fatalities by ensuring that more people have immediate access to this critical medication.